Red Cedar Investment Management LLC Sells 2,379 Shares of Stryker Corporation $SYK

Red Cedar Investment Management LLC lowered its position in Stryker Corporation (NYSE:SYK) by 34.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,563 shares of the medical technology company’s stock after selling 2,379 shares during the period. Red Cedar Investment Management LLC’s holdings in Stryker were worth $1,604,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in SYK. Godfrey Financial Associates Inc. purchased a new position in shares of Stryker in the 4th quarter worth approximately $26,000. United Financial Planning Group LLC purchased a new stake in shares of Stryker during the third quarter valued at approximately $27,000. Strive Asset Management LLC bought a new stake in Stryker during the third quarter worth $30,000. CGC Financial Services LLC purchased a new position in Stryker in the fourth quarter worth $29,000. Finally, ANTIPODES PARTNERS Ltd purchased a new position in Stryker in the third quarter worth $34,000. 77.09% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

SYK has been the subject of several research analyst reports. Leerink Partners decreased their target price on Stryker from $410.00 to $407.00 and set an “outperform” rating for the company in a research report on Friday. Truist Financial reissued a “hold” rating and issued a $330.00 price target (down from $380.00) on shares of Stryker in a report on Monday, May 4th. Deutsche Bank Aktiengesellschaft set a $315.00 price target on shares of Stryker in a research report on Friday, May 1st. William Blair reaffirmed an “outperform” rating on shares of Stryker in a research report on Thursday, March 5th. Finally, Citigroup dropped their target price on shares of Stryker from $420.00 to $385.00 and set a “buy” rating on the stock in a research note on Tuesday, April 7th. Sixteen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $395.33.

Insider Transactions at Stryker

In related news, VP Robert S. Fletcher sold 4,544 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total value of $1,394,417.28. Following the completion of the transaction, the vice president directly owned 10,582 shares of the company’s stock, valued at approximately $3,247,298.34. This trade represents a 30.04% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP M Kathryn Fink sold 5,220 shares of Stryker stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $283.85, for a total transaction of $1,481,697.00. Following the completion of the transaction, the vice president owned 13,137 shares of the company’s stock, valued at $3,728,937.45. This represents a 28.44% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 323,264 shares of company stock worth $100,659,489 over the last quarter. Corporate insiders own 4.60% of the company’s stock.

Stryker Stock Performance

Shares of SYK opened at $314.41 on Wednesday. Stryker Corporation has a 1 year low of $281.00 and a 1 year high of $404.87. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25. The stock’s fifty day moving average price is $317.55 and its two-hundred day moving average price is $345.01. The firm has a market cap of $120.53 billion, a PE ratio of 36.39, a PEG ratio of 1.90 and a beta of 0.78.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The firm had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. During the same quarter in the previous year, the company posted $2.84 EPS. The firm’s revenue was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. On average, equities research analysts forecast that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be paid a $0.88 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. Stryker’s dividend payout ratio (DPR) is presently 40.74%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.